ONCY -- Cancer Virus Blockbuster .. SAVA CMS Update .. SCPH Launch

Join the Small Caps Newsletter for early access to reports on two new small caps each month, plus the Discord and Book "Guide to Crushing the Market":

Sign, Comment, and Share the Petition to Get Simufilam to Alzheimer's Patients:

Videos are not financial advice

00:00 Intro
05:48 Oncolytics Cancer Blockbuster
33:15 SAVA CMS Timing
35:31 Phones

#biotech
#financialfreedom
#investorsclub

[MegaNagin]

To answer the question presented re Head & Neck & Lung Cancer trial results. The difference was that those trials did not include Immune Checkpoint Inhibitors as combination therapy. Only since 2018 when two biomarkers were found were ICI's begun to be trialed in combination therapy with Pelareorep. What we are seeing from the Goblet and Aware results is what the CEO Matt Coffey has been saying, which is that Pelareorep needs to be re-trialed in combination with ICI's on a wide variety of indications including Head & Neck & Lung Cancer. Pelareorep turns cold tumors hot for immunotherapy to work, and most likely turns hot tumors hotter. ONCY is a story worth digging into.

[_TruthNow]

A blockbuster is 100% CR without a relapse. "only one of the 20 patients with a complete response had relapsed" Cargo.